id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-E-0148-0002,FDA,FDA-2001-E-0148,Letter from Associate Director for Policy Center for Drug Evaluation and Research to  U.S. Patent and Trademark Office,Other,Letter(s),2003-07-28T04:00:00Z,2003,7,,,2025-10-10T00:20:29Z,,0,0,09000064804ddca7